Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year

APTA Results (4,511 Results)

Includes articles, courses, and CPGs. Unlimited access for APTA members.

A New Review Process, More Cost Transparency: CAPTE Looks Ahead

Jun 6, 2022/Roundup

The profession's education accreditation body is achieving current goals while shaping the future. Here's an overview of what's happening.

Top APTA Magazine Articles of 2024

Jan 17, 2025/Article

APTA Magazine brought members content that explores the issues the profession is talking about in 2024.

Risk Assessment Prediction Tool (RAPT)

May 23, 2017/Test & Measure

Risk Assessment Prediction Tool (RAPT)

Technology's Brave New World of Ethical Challenges Explored in PT in Motion Magazine

Nov 6, 2019/News

That latest piece of technology you're thinking about weaving into your practice? Maybe it should come with a warning label. This month, PT in Motion magazine takes a look at the ethical issues that new technologies can introduce in physical therapist practice. From seemingly offhand social media posts

Awards for APTA

See recent awards won by the American Physical Therapy Association.

Value-Based Care Podcasts

APTA's comprehensive podcast series explains the move toward value-based care and how physical therapists can participate in the Quality Payment Program

International Physical Therapy Education

There's a lot to consider when deciding whether to earn a physical therapy degree outside of the United States.

APTA Patient Action Center

APTA's Patient Action Center contains letters focused on the patient impact of certain federal issues and bills.

From Students to Fellows: Celebrating Leadership Across the Profession

Nov 1, 2025/Feature

Meet the seasoned leaders, emerging trailblazers, and outstanding students who are driving the profession forward.

Weighty Matters: Physical Therapy and GLP-1 Medications

Aug 1, 2025/Feature

What PTs need to know about working with patients taking glucagon-like peptide-1 agonists.